Ame Company For Medical Supplies (9527) Fundamentals 2026 — P/E 15.1x, Revenue Analysis | SniperIQ
Ame Company For Medical Supplies (9527) is a SA-listed Healthcare company in Medical - Distribution with a market capitalization of SAR 495M, trading at SAR 70.75 on the SAU. This SniperIQ fundamentals page covers Ame Company For Medical Supplies's valuation (P/E 15.1x, P/B 2.8x), profitability (net margin 9.6%), revenue (SAR 305M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Ame Company For Medical Supplies's market cap?
Ame Company For Medical Supplies (9527) has a market capitalization of approximately SAR 495M, trading at SAR 70.75 on the SAU. Market cap moves with the live share price.
What is Ame Company For Medical Supplies's P/E ratio?
Ame Company For Medical Supplies's trailing twelve-month P/E ratio is 15.1x, with a price-to-book (P/B) of 2.8x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Ame Company For Medical Supplies?
Ame Company For Medical Supplies runs a net profit margin of 9.6%, a gross margin of 41.6%, and an operating margin of 11.3%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Ame Company For Medical Supplies generate?
Ame Company For Medical Supplies reported revenue of SAR 305M for fiscal year 2025, with net income of SAR 35M and earnings per share (EPS) of 5. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Ame Company For Medical Supplies pay a dividend?
Ame Company For Medical Supplies offers a trailing dividend yield of about 2.8%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Ame Company For Medical Supplies financially healthy?
Ame Company For Medical Supplies carries a debt-to-equity ratio of 0.16x and a current ratio of 3.28x, with a market beta of -0.05. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Ame Company For Medical Supplies a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Ame Company For Medical Supplies (9527) the key facts are: market cap SAR 495M, P/E 15.1x, revenue SAR 305M, 52-week range 70-140. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Ame Company For Medical Supplies's full fundamentals live
Get Ame Company For Medical Supplies's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.